Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9

...

Roche's $50 Billion US Investment Commitment Includes New Facilities, 12,000 Jobs, Expanded R&D Hubs As Drug Tariffs Loom

April 22, 2025

What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?

April 14, 2025

Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight

April 11, 2025

Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success

April 10, 2025

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline

April 09, 2025

Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today

April 09, 2025

Roche To Start Phase 3 Study For Alzheimer's Prospect This Year After New Data From Phase 2

April 04, 2025

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry

April 04, 2025

Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death

April 03, 2025

Why Is Pharma Giant Roche Stock Trading Lower On Wednesday?

April 02, 2025

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

March 21, 2025

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

March 19, 2025

The Best Vanguard ETF to Invest $1,000 in Right Now

March 18, 2025

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

March 12, 2025

Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs

March 12, 2025

Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy

March 03, 2025

NovoCure Q4 EPS Misses, Revenue Matches

February 27, 2025

Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data

January 28, 2025

Sarepta Therapeutics' Duchenne Gene Therapy Shows Sustained Benefits And Disease Stabilization At Two Years

January 27, 2025

Legal Marijuana Linked To Drop In Anxiety Medications: What It Means For Pharma Giants

January 21, 2025

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

January 16, 2025

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

December 31, 2024

Roche CEO Reassures No Job Cuts Despite Challenges: Report

December 30, 2024

Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits

December 19, 2024

Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

December 18, 2024

United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis

December 13, 2024

Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?

November 27, 2024

Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details

November 26, 2024

Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks

November 08, 2024

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

October 30, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.